Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
BioVie (BIVI)
NASDAQ:BIVI
BIVI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.04 - $33.10
Previous CloseN/A
Volume1.62M
Average Volume (3M)866.09K
Market Cap
$32.84M
Enterprise Value$1.75M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.37
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.95
Shares Outstanding18,451,980
10 Day Avg. Volume621,723
30 Day Avg. Volume866,092
Standard Deviation0.45
R-Squared0.01
Alpha0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.05
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-7.62
Enterprise Value/Ebitda-0.08
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
BioVie News
PremiumCompany Announcements
BioVie Raises $3.24 Million in Direct Offering
PremiumCompany Announcements
BioVie Raises Capital Through Direct Stock Offering
---
Ownership Overview
9.37% Insiders
0.97% Mutual Funds
1.18% Other Institutional Investors
88.00% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
BIVI FAQ
What was BioVie’s price range in the past 12 months?
BioVie lowest stock price was $1.04 and its highest was $33.10 in the past 12 months.
What is BioVie’s market cap?
BioVie’s market cap is $32.84M.
When is BioVie’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were BioVie’s earnings last quarter?
BioVie released its earnings results on Feb 14, 2024. The company reported -$0.22 earnings per share for the quarter, beating the consensus estimate of -$0.275 by $0.055.
Is BioVie overvalued?
According to Wall Street analysts BioVie’s price is currently Overvalued.
Does BioVie pay dividends?
BioVie does not currently pay dividends.
What is BioVie’s EPS estimate?
BioVie’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BioVie have?
BioVie has 18,451,980 shares outstanding.
What happened to BioVie’s price movement after its last earnings report?
BioVie reported an EPS of -$0.22 in its last earnings report, beating expectations of -$0.275. Following the earnings report the stock price went down -0.823%.
Which hedge fund is a major shareholder of BioVie?
Among the largest hedge funds holding BioVie’s share is Sheaff Brock Investment Advisors LLC. It holds BioVie’s shares valued at 0.
---
BioVie Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 5.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 0.8%
Last 30 Days ▼ 1.0%
Last 30 Days ▼ 1.0%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-86.09%
12-Months-Change
Fundamentals
Return on Equity
-154.54%
Trailing 12-Months
Asset Growth
19.56%
Trailing 12-Months
Company Description
BioVie
BioVie, Inc. is a development stage biopharmaceutical company, which discovers, develops, and commercializes drug therapies for liver disease. It focuses on BIV201 which treats ascites due to chronic liver cirrhosis. The company was founded on April 10, 2013 and is headquartered in Santa Monica, CA.
---
BIVI Stock 12 Month Forecast
Average Price Target
―Technical Analysis
ACADIA Pharmaceuticals
―
Cassava Sciences
―
Anavex Life Sciences
―
Axsome Therapeutics
―
Inmune Bio
―
Best Analysts Covering BIVI
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-53.90%
initiated a buy rating 8 months ago
Copying Ashok Kumar's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -53.90% per trade.
---